Dipraseodymium oxide silicate(12401-47-7)
- Name: Dipraseodymium oxide silicate
- Synonyms:dipraseodymium oxide silicate
- Molecular Formula:O12Pr2Si3-6
- Molecular Weight:558.0646
- CAS Registry Number:12401-47-7
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.12401-47-7 Dipraseodymium oxide silicate
Assay:99% Appearance:powder or liquid Package:according to customer requirements Storage:store in dry dark and ventilated place Transportation:By Sea/Air/Courier Application:It is an important raw material.
Min. Order:10Gram
Supplier:Zibo Hangyu Biotechnology Development Co., Ltd [
China (Mainland)] CAS No.12401-47-7 Dipraseodymium oxide silicate
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.12401-47-7 Dipraseodymium oxide silicate
Assay:99% Application:healing drugs
Min. Order:0
Supplier:Antimex Chemical Limied [
China (Mainland)] CAS No.12401-47-7 Dipraseodymium oxide silicate
Assay:98%min Appearance:Off-white to light yellow powder Package:According to the clients requirement. Storage:Keep in cool place. Application:Pharmaceutical intermediates
Min. Order:0
Supplier:Hangzhou J&H Chemical Co., Ltd. [
China (Mainland)] CAS No.12401-47-7 Dipraseodymium oxide silicate
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:Dipraseodymium oxide silicate
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)]
Other Product
- 7131-84-2/2-(4-methylpiperazin-1-yl)-6-(2-methylpropyl)-4-(morpholin-4-yl)-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine
- 78693-90-0/RMI 10222F
- 5409-52-9/1-(4-chlorophenyl)-3-(diethylamino)propan-1-one
- 130007-50-0/Pentoxifylline-alpha-methoxy-alpha-(trifluoromethyl)phenylacetate ester
- 615-67-8/Chlorohydroquinone
- 2439-85-2/N-BROMOPHTHALIMIDE
- 90994-48-2/nerve growth factor (10-25,75-88)
- 24932-03-4/3'H-Cycloprop[2,3]androsta-2,5-diene(8CI,9CI)
- 18976-74-4/Reactive Yellow 14
- 56386-98-2/POLYURETHANE Y-226
- 4948-29-2/cis-2-Pinanol
- 28444-83-9/4-chloro-17-hydroxy-3,11,20-trioxopregn-4-en-21-yl acetate
- 1111-64-4/lithium hydrogenacetylide
- 1317-43-7/Brucite (Mg(OH)2)
- 38690-79-8/4-[(4-propylbenzylidene)amino]benzonitrile
- 13169-00-1/METHOXYALLENE; 95%DISCONTINUED 05/24/01
- 68511-84-2/Lignosulfonic acid, reaction products with diethylenetriamine
- 63886-30-6/1-(7,8-dimethoxy-1,2,3,4-tetrahydronaphthalen-1-yl)pyrrolidine hydrochloride
- 178980-03-5/1-{5-[(3,5-dichlorophenyl)sulfinyl]-1-methyl-4-(1-methylethyl)-1H-imidazol-2-yl}methanamine
- 12401-47-7/Dipraseodymium oxide silicate
- 146388-20-7/2'-(trimethylammonio)ethyl-4-(hexadecyloxy)-3-methoxybutane phosphonate
- 6194-09-8/N~2~-(2-chlorophenyl)-N-(2,4-dimethylphenyl)-N~2~-[(4-methylphenyl)sulfonyl]glycinamide
- 31499-90-8/2,1-Benzisoxazol-3(1H)-one
- 114056-26-7/vasotocin, (beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)-O-methyl-Tyr(2)-Thr(4)-Orn(8)-Tyr(9)-NH2
- 938-25-0/1,2-DIAMINONAPHTHALENE
- 69675-10-1/Paroxetine EP IMpurity G
- 2051-78-7/ALLYL BUTYRATE
- 5730-68-7/(5Z)-5-{3-bromo-5-methoxy-4-[(4-nitrobenzyl)oxy]benzylidene}-1-phenyl-2-thioxodihydropyrimidine-4,6(1H,5H)-dione
- 16907-79-2/QUINALDIC ACID SODIUM SALT
- 97593-24-3/Fatty acids, C8-21 and C8-21-unsatd., esters with lactic acid, calcium salts